Skip to main navigation Skip to search Skip to main content

Repeated-measures models to evaluate a hepatitis B vaccination programme

  • Akke Vellinga

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

Abstract

In 1985-1986, a hepatitis B vaccination programme was conducted in a Belgian institution for the mentally handicapped. A group of 97 residents was followed up for 11 years in order to characterize the long-term persistence of hepatitis B antibodies after vaccination. This paper proposes the use of linear mixed-effects models to account for serial correlation and between-individual heterogeneity in the data, while adjusting the analysis for various individual characteristics and important risk factors in the response to vaccination. We propose several model building strategies and focus on the prediction of future levels of antibodies.In 1985-1986, a hepatitis B vaccination programme was conducted in a Belgian institution for the mentally handicapped. A group of 97 residents was followed up for 11 years in order to characterize the long-term persistence of hepatitis B antibodies after vaccination. This paper proposes the use of linear mixed-effects models to account for serial correlation and between-individual heterogeneity in the data, while adjusting the analysis for various individual characteristics and important risk factors in the response to vaccination. We propose several model building strategies and focus on the prediction of future levels of antibodies.
Original languageEnglish (Ireland)
JournalStat Med
Volume20
Issue number66
Publication statusPublished - 1 Mar 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Authors (Note for portal: view the doc link for the full list of authors)

  • Authors
  • Renard, D.,Bruckers, L.,Molenberghs, G.,Vellinga, A.,Van Damme, P.

Fingerprint

Dive into the research topics of 'Repeated-measures models to evaluate a hepatitis B vaccination programme'. Together they form a unique fingerprint.

Cite this